Sort
48,018 grants matching “immunotherapy”
Research Training in Hematology
$414,094John Patrick Sheehan · University Of Wisconsin-Madison · T32 · FY2019 · HL
An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation
$414,083Joseph E Craft · Yale University · R61 · FY2018 · AR
Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
$414,073Zachary Conrad Hartman · Duke University · R01 · FY2020 · CA
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$414,046David J Mooney · Harvard University · R01 · FY2020 · CA
Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines
$414,042Michael D Robek · Albany Medical College · R01 · FY2016 · AI
Project 1: FLASH vs. Standard radiotherapy for treatment of PDAC and sparing normal intestine tissues
$414,042Constantinos Koumenis · University Of Pennsylvania · P01 · FY2023 · CA
Pathogenesis and treatment of sporadic Inclusion Body Myositis in mouse models.
$413,993Thomas E. Lloyd · Johns Hopkins University · R01 · FY2020 · AR
Development of a novel imaging modality for adoptive cell therapy
$413,974David Wald · Case Western Reserve University · R21 · FY2021 · CA
Investigating a Novel Inhibitory Receptor in Regulating CAR-T Cell Persistence and Function
$413,971Li Lily Wang · Cleveland Clinic Lerner Com-Cwru · R21 · FY2024 · CA
Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
$413,970John H Sampson · Duke University · R01 · FY2019 · CA
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
$413,965Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · AG
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$413,953Song Li · University Of California Los Angeles · R01 · FY2021 · CA
T-Cell Responses Predict Influenza Risk in Older Adults
$413,917Janet E. McElhaney · University Of Connecticut Sch Of Med/Dnt · R01 · FY2007 · AI
Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs
$413,916Wendell A Lim · University Of California, San Francisco · R01 · FY2021 · CA
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging
$413,866Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2022 · CA
Intra- and inter-cellular signals that drive hepato-oncogenesis
$413,831Gen-Sheng Feng · University Of California, San Diego · R01 · FY2023 · CA
Hiv Immune Reactivity 'in Vivo' and 'In Vitro'
$413,792Kendall A Smith · Weill Medical Coll Of Cornell Univ · R01 · FY2006 · AI
Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition
$413,778Robert M Prins · University Of California Los Angeles · P50 · FY2024 · CA
Role of Neutralizing Antibodies in Transmission of SHIV
$413,771Nancy Logan Haigwood · Seattle Biomedical Research Institute · R01 · FY2008 · HD
Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model
$413,761Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Tissue-specific Borrelia Gene Expression
$413,750Erol Fikrig · Yale University · R37 · FY2011 · AI
Fcgamma mediated regulation of dendritic cell function
$413,750Kavita Dhodapkar · Yale University · R01 · FY2009 · AI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$413,715Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
$413,702Philip Abbosh · Research Inst Of Fox Chase Can Ctr · U01 · FY2023 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$413,641Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2021 · NS